Skip to main content

Table 6 Sub-group analysis of item responses by Study Size (in quartiles)

From: Risk of bias of randomized controlled trials published in orthopaedic journals

Randomization

Y

N

DK

Size < 51

35(61.4)

5(8.8)

17(29.8)

51 ≤ size < 81

41(70.7)

5(8.6)

12(20.7)

81 ≤ size < 158

53(84.1)

3(4.8)

7(11.1)

Size ≥ 158

36(59.0)

4(6.6)

21(34.4)

Allocation Concealment

Size < 51

33(57.9)

4(7.0)

20(35.1)

51 ≤ size < 81

42(72.4)

5(8.6)

11(19.0)

81 ≤ size < 158

52(82.5)

3(4.8)

8(12.7)

Size ≥ 158

37(60.7)

3(4.9)

21(34.4)

Blinding of Participants

Size < 51

9(15.8)

10(17.5)

38(66.7)

51 ≤ size < 81

9(15.5)

10(17.2)

39(67.2)

81 ≤ size < 158

15(23.8)

19(30.2)

29(46.0)

Size ≥ 158

16(26.2)

12(19.7)

32(54.1)

Blinding of Assessors

Size < 51

25(43.9)

7(12.3)

25(43.9)

51 ≤ size < 81

30(51.7)

10(17.2)

18(31.0)

81 ≤ size < 158

34(54.0)

9(14.3)

20(31.8)

Size ≥ 158

29(47.5)

12(19.7)

20(32.8)

Outcome Measurement

Size < 51

54(94.7)

1(1.8)

2(3.5)

51 ≤ size < 81

54(93.1)

1(1.7)

3(5.2)

81 ≤ size < 158

61(96.8)

0(0)

2(3.2)

Size ≥ 158

56(91.8)

0(0)

5(8.2)

Similarly Trained Individuals

Size < 51

29(50.9)

1(1.8)

27(47.4)

51 ≤ size < 81

38(65.5)

0(0)

20(34.5)

81 ≤ size < 158

31(49.2)

2(3.2)

30(47.6)

Size ≥ 158

15(24.6)

0(0)

46(75.4)

Compliance with Intervention

Size < 51

28(49.1)

29(5.9)

0(0)

51 ≤ size < 81

39(67.2)

18(31.0)

1(1.7)

81 ≤ size < 158

53(84.1)

10(15.9)

0(0)

Size ≥ 158

46(75.4)

15(24.6)

0(0)

Intent to Treat Analysis

Size < 51

10(17.5)

0(0)

47(82.5)

51 ≤ size < 81

15(25.9)

0(0)

43(74.1)

81 ≤ size < 158

39(61.9)

1(1.6)

23(36.5)

Size ≥ 158

39(63.9)

3(4.9)

19(31.1)

Clustering

Size < 51

0(0)

0(0)

57(100)

51 ≤ size < 81

0(0)

0(0)

58(100)

81 ≤ size < 158

1(1.6)

0(0)

62(98.4)

Size ≥ 158

0(0)

0(0)

61(100)

Similar at Baseline

Size < 51

37(64.9)

2(3.5)

18(31.6)

51 ≤ size < 81

39(67.2)

3(5.2)

16(27.6)

81 ≤ size < 158

47(74.6)

7(11.1)

9(14.3)

Size ≥ 158

45(73.8)

8(13.1)

8(13.1)